RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY

RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY

ABSTRACT Background Variceal hemorrhage (VH) is a medical emergency. Prompt endoscopic variceal ligation (EVL) is therapeutic. Terlipressin is used in VH and continued for 2—5 days even after EVL. As hemostasis is primarily achieved by EVL, the benefit of continuing trelipressin after EVL is unknow...

Full description

Bibliographic Details
Main Authors: Ram Chandra POUDEL, Deba Prasad DHIBAR, Navneet SHARMA, Vishal SHARMA, Sunil TANEJA, Ajay PRAKASH
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) 2022-04-01
Series:Arquivos de Gastroenterologia
Subjects:
Terlipressin
variceal hemorrhage
endoscopic variceal ligation
re-bleed
mortality
adverse drug reaction
portal hypertension
chronic liver disease
cirrhosis
gastrointestinal bleed
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032022000100089&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032022000100089&tlng=en

Similar Items